The 2023-2024 Pilot Projects competition is open!
The program offers funding in the amount of $20,000 to support pilot projects related to multi-center and multidisciplinary bio-imaging projects in humans and/or animal models.
Latest news and updates
The program offers funding in the amount of $20,000 to support pilot projects related to multi-center and multidisciplinary bio-imaging projects in humans and/or animal models.
Congratulations to the recipients of our 2023-2024 scholarships – we wish everyone great success in their projects!
For the third year running, The Neuro’s Tanenbaum Open Science Institute (TOSI) is pleased to announce the opening of The Neuro – Irv and Helga Cooper Foundation Open Science Prizes.
A research team led by Roger Lecomte at the Université de Sherbrooke has developed an ultrahigh-resolution (UHR) brain PET scanner, enabling effective visualization and understanding of biological processes taking place in small cerebral structures.
The Travel for Training Awards program is now accepting applications for reimbursement of travel taking place between October 1st, 2023 and March 31st, 2024.
The Ordre des technologues en imagerie médicale, radiooncologie et électrophysiologie médicale (OTIMROEPMQ) is looking for speakers for its continuing education activities.
The 2023 edition of the QBIN Scientific Day was a great success! Held in-person on May 25th at the Pavillon Alphonse-Desjardins of the Université Laval, this event brought together a passionate and engaged crowd eager to explore the latest advancements in bio-imaging.
Congratulations to the three winners of the 2023 QBIN Open Science Awards, Alex Valcourt Caron, Jessica Royer, and Jérôme Dockès! Each winner will receive $2,000 in recognition of their work to advance Open Science in Quebec and/or internationally through their research practices and/or through outreach initiatives related to the field of bio-imaging.
A new approach has enabled 71 research centers, including the Institut de recherche sur le cancer de l’Université de Sherbrooke (IRCUS), to rapidly advance knowledge about glioblastoma, a rare and very aggressive form of brain cancer.
The creation of a new generation of injectable radiotherapy treatments could become a reality.